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Tandem mass spectrometry performed on a pool of 18 oligopeptides shows that the product
ion spectra of argentinated peptides, the [bn 1 OH 1 Ag]
1 ions and the [yn 2 H 1 Ag]
1 ions
bearing identical sequences are virtually identical. These observations suggest strongly that
these ions have identical structures in the gas phase. The structures of argentinated glycine,
glycylglycine, and glycylglycylglycine were calculated using density functional theory (DFT)
at the B3LYP/DZVP level of theory; they were independently confirmed using HF/
LANL2DZ. For argentinated glycylglycylglycine, the most stable structure is one in which Ag1
is tetracoordinate and attached to the amino nitrogen and the three carbonyl oxygen atoms.
Mechanisms are proposed for the fragmentation of this structure to the [b2 1 OH 1 Ag]
1 and
the [y2 2 H 1 Ag]
1 ions that are consistent with all experimental observations and known
calculated structures and energetics. The structures of the [b2 2 H 1 Ag]
1 and the [a2 2 H 1
Ag]1 ions of glycylglycylglycine were also calculated using DFT. These results confirm earlier
suggestions that the [b2 2 H 1 Ag]
1 ion is an argentinated oxazolone and the [a2 2 H 1
Ag]1 an argentinated immonium ion. (J Am Soc Mass Spectrom 2001, 12, 163–175) © 2001
American Society for Mass Spectrometry
Identifying the sequence of amino acid residues isoften the first step in a study of the function of anunknown protein. This is traditionally accomplished
by means of Edman degradation [1]. Gas-phase micro-
sequencing by means of tandem mass spectrometry has
increasingly been applied to obtain partial, or even
complete, sequences of unknown peptides [2–4]. In the
last couple of years, a major application of the above has
been in the area of proteome analysis, where partial
sequences of enzymatically cleaved peptides have been
used for the purpose of protein identification via the
so-called “sequence tag” method [5, 6]. Mass spectro-
metry’s major advantages in chemical analysis have
been well documented [7] and are applicable to peptide
sequencing.
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A low (,100 eV) energy collision-induced dissocia-
tion spectrum of a protonated peptide typically consists
of series of b, a, and y fragment ions which reflect the
amino acid sequence [2–4]. In solution, the most basic
sites on a peptide are the nitrogen atoms at the N-
terminal amino group and the side chains of the histi-
dine, lysine, and arginine residues [8, 9]. However, once
the protonated peptide ion has been desorbed into the
gas phase, e.g., via electrospray [10], transfer of the
“external” proton, particularly after collisional activa-
tion, to amidic functional groups, the carbonyl oxygen
and the amidic nitrogen atoms, on the backbone be-
comes possible [11–14]. The peptide then fragments at
the protonated peptide linkage to yield an ionic and a
neutral fragment [2–4, 11–38]. If the charge is retained
on the N-terminal fragment, a b ion is produced; the b
ion may subsequently lose CO to form the a ion.
Alternatively, if the charge is retained on the C-terminal
fragment, a y ion is produced. The b ion was long
regarded to be an acylium ion [2–4]; however, recent
results from a series of studies by Harrison’s [33–35],
Wesdemiotis’ [36, 37], and Hunt’s [38] groups have
established that the b ion has an oxazolone structure,
which fragments after collisional activation to produce
the a ion, an immonium ion, via an acylium activated
complex. The y ion has been found to be a protonated
peptide or amino acid [2–4, 11–14].
The silver ion binds to peptides and proteins in
solution; this fact is exploited in the preparation of
heavy-atom derivatives of proteins in crystallography
[39]. The metallothioneins, small, cysteine-rich proteins
that are believed to be involved in heavy-metal detox-
ification, exhibit very high affinities for Ag(I) [40–42].
Li et al. [43] showed that methionine-containing pep-
tides produce comparatively more intense silver(I)–
peptide complexes than their nonmethionine-contain-
ing analogs. This apparent selective binding of Ag(I) to
methionine, however, was not evident in a comparison
of the collision-induced dissociation of these argentin-
ated complexes—most silver-containing fragment ions
did not contain the methionine residue. This led Li et al.
[43] to postulate that a rearrangement must have oc-
curred in the gas phase in which desolvation results in
self-solvation of the amidic carbonyl groups around the
silver(I) ion thus leading to weakening of the silver–
methionine bond. Fragmentation of argentinated pep-
tides yields abundant [bn 2 H 1 Ag]
1, [an 2 H 1
Ag]1, [yn 2 H 1 Ag]
1, and [bn 1 OH 1 Ag]
1 ions
(nomenclature based on definitions by Biemann in [44])
that are indicative of the residue sequence and suggests
either a heterogeneous precursor ion structure in which
the silver ion is “mobile” or a distribution of fixed,
silver-containing ion structures. The constant m/z dif-
ferences of 18 units between the [bn 1 OH 1 Ag]
1 and
the [bn 2 H 1 Ag]
1 ions, and 28 units between the
[bn 2 H 1 Ag]
1 and [an 2 H 1 Ag]
1 ions of the same
n (residue), have been exploited as markers in a semi-
automated identification algorithm for sequencing
based on argentinated peptides [45]. From studying the
product ion spectra of the [b2 2 H 1 Ag]
1 ion of
argentinated tripeptides and comparing them with
those of argentinated 2-phenyl-5-oxazolones, some-
times with the aid of H/D-exchanged peptides, Lee et
al. [46] concluded that the [b2 2 H 1 Ag]
1 ion is an
argentinated oxazolone, the sequential fragmentation of
which leads to the [a2 2 H 1 Ag]
1 ion, an argentinated
immonium ion.
In this article, we examine the structures of the other
two major product ions, the [bn 1 OH 1 Ag]
1 and the
[yn 2 H 1 Ag]
1 ions, produced in the fragmentation of
argentinated peptides. Assignment will be made based
on comparison of the product ion spectra of these ions
with those of the proposed argentinated structures.
Density functional theory (DFT) and ab initio molecular
orbital calculations will be used to assist in assigning
structures and relative energies to the ions produced
due to fragmentation. Mechanisms for the formation of
these ions will be proposed. Furthermore, the energies
of the stable structures of the [b2 2 H 1 Ag]
1 and the
[a2 2 H 1 Ag]
1 ions of glycine residues as calculated
using DFT will be reported.
Experimental
Experiments were conducted on two PE SCIEX triple
quadrupole mass spectrometers, an API 365 and an API
III (Concord, Ontario). All but two oligopeptides were
commercially available (Sigma, St. Louis, MO). The
exceptions are betaine-AG and betaine-AGA, which
were custom synthesized by Dalton Chemical Labora-
tories (Toronto, Ontario). Samples were typically 2 mM
peptides in 50/50 water/methanol containing 10 mM
silver nitrate (Aldrich, St. Louis, MO). These were
continuously infused by means of a syringe pump
(Harvard Apparatus, Model 22, South Natick, MA) at a
typical flow rate of 2 mL/min into the pneumatically
assisted electrospray probe with air being the nebuliz-
ing gas. The optimum probe position was established
from time to time but was typically with the tip about 2
cm from the interface plate and with the spray off-axis
from the orifice. Mass spectra were acquired in the
positive ion detection mode with unit mass resolution
at a step size of 0.1 m/z unit and at a dwell time of 10
ms/step. Typically, 10 scans were summed to produce
a mass spectrum. Tandem mass spectrometry was per-
formed with a nitrogen pressure of approximately 3
mtorr in q2 and at a collision energy at the centre-of-
mass frame (Ecm) typically of 1–3 eV (equivalent to
laboratory-frame energies of 15–45 eV for most pep-
tides). Apparent MS3 was accomplished by raising the
orifice bias potential to induce fragmentation in the lens
region, mass selecting the appropriate product ion in
Q1, inducing its fragmentation in q2, and mass analyz-
ing the second generation product ions in Q3.
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Computational Methods
Density functional theory employing the hybrid B3LYP
method, which uses Becke’s three-parameter exchange
functional [47] and the correlation functional from Lee,
Yang, and Parr [48, 49], in the Gaussian 98 program [50]
was utilized along with the double zeta valence polar-
ization (DZVP) basis set [51]. Geometric optimizations
were performed on a large number of plausible starting
structures, and several of these collapsed to identical
minima. All structures were confirmed to be at minima
by harmonic frequency calculations. These conclusions
were independently verified by ab initio calculations
using HF/LANL2DZ [52]. Zero-point energies and
thermal corrections obtained from the DFT calculations
were used to determine relative enthalpies at 298 K.
Finally, entropy terms were included to obtain relative
free energies.
Results and Discussion
Mass Spectrometry
Figure 1a shows the product ion spectrum of the [b2 1
OH 1 107Ag]1 ion of alanylalanylalanine, AAA. Silver
has two stable isotopes, 107Ag and 109Ag, of almost
equal abundance. The product ion spectra in this article
are those of either 107Ag or 109Ag; the identity of the
silver isotope will be specified. Description of silver in
the text will generally carry no isotope identity as it is
applicable to ions of both isotopes, although the discus-
sion may stem from product and precursor ions of only
one isotope selected. Figure 1b shows the product ion
spectrum of the [M 1 107Ag]1 ion of alanylalanine, AA.
It is evident that the two spectra are almost identical.
The major product ion at m/z 196 is assigned [b1 1
OH 1 Ag]1/[y1 2 H 1 Ag]
1 (the two ions are isobar-
ic). The striking similarity between the product ion
spectra of the [bn 1 OH 1 Ag]
1 ion of an oligopeptide
and the [M 1 Ag]1 of an oligopeptide containing iden-
tical residues is repeatedly observed in the following
pairs of peptides examined (the residues of the [bn 1
OH 1 Ag]1 ions are shown in italics): GAA, GA; GGA,
GG; AAA, AA; AAAA, AA; AAAAA, AAAA; and
GGGG, GGG. For example, Figure 1c, d shows a com-
parison between the product ion spectra of the [b3 1
OH 1 107Ag]1 ion of AAAAA and the [M 1 107Ag]1
ion of AAA.
Figure 2 shows product ion spectra of (a) leucine
enkephalin, YGGFL, and (b) leucine enkephamide,
YGGFL–NH2 (YGGFL whose C-terminal functional
group is an amide instead of a carboxylate), measured
under identical experimental conditions. It is readily
apparent that the spectra are very similar save for the
absence of the [bn 1 OH 1 Ag]
1 product ions in the
fragmentation of YGGFL–NH2. The absence of [bn 1
OH 1 Ag]1 was also observed in the product ion
spectra of the methyl ester and the ethyl ester of leucine
enkephalin (spectra not shown). These data clearly
show that the C-terminal carboxylate is essential for the
formation of the [bn 1 OH 1 Ag]
1 ion.
Figure 3 shows a comparison of the product ion
spectra of (a) the [y2 2 H 1
109Ag]1 ion of alanylleucyl-
glycine and (b) the [M 1 109Ag]1 ion of leucylglycine. It
is apparent that the two product ion spectra are nearly
identical. Repeating the experiments in D2O/CH3OD
showed that the [y2 2 H 1 Ag]
1 and the [y1 2 H 1
Ag]1 ions are d4 and d3, respectively, which means that
the ionic fragment receives an exchangeable (N or O
attached) proton from the neutral fragment during the
rearrangement that leads to fragmentation. A similar
proton transfer has also been observed in the formation
of y ions from protonated peptides [2–4, 36, 53]. Con-
verting the N-terminal amino group to an amide has
apparently little effect on the abundance of the [yn 2
H 1 Ag]1 ions; both N-acetyl and N-benzoyl propylg-
lycylglycine exhibit [yn 2 H 1 Ag]
1 ions of compara-
ble abundance to those of underivatized propylglycyl-
glycine. Again, the striking similarity between the
product ion spectra of the [yn 2 H 1 Ag]
1 ion of an
oligopeptide and the [M 1 Ag]1 of an truncated pep-
tide containing identical residues is repeatedly ob-
served in the following pairs of peptides examined (the
residues of the [yn 2 H 1 Ag]
1 ions are shown in
italics): APG, PG; ALG, LG; AGG, GG; GHG, HG; and
GGA, GA.
The product ion spectra of the [bn 1 OH 1 Ag]
1 ion
and the [yn 2 H 1 Ag]
1 ion containing identical resi-
dues are compared in Figure 4: (a) the [b2 1 OH 1
107Ag]1 ion of GLA with (b) the [y2 2 H 1
107Ag]1 ion
of GGL, and (c) the [b2 1 OH 1
107Ag]1 ion of GFA
with (d) the [y2 2 H 1
107Ag]1 ion of GGF. It is evident
that the spectra of the members of the pairs are virtually
identical.
Taken as a whole, the above results suggest very
strongly that the [bn 1 OH 1 Ag]
1, the [yn 2 H 1
Ag]1 and the [M 1 Ag]1 ions of identical residues have
identical structures and they are all argentinated pep-
tides. Key argentinated glycine, glycylglycine, and gly-
cylglycylglycine structures calculated at the B3LYP/
DZVP level of theory are shown in Table 1 and the ion
structures are given in Figure 5. Results of HF/
LANL2DZ are very similar and these are not shown for
simplicity. Glycine and the di- and tripeptides formed
by condensation of glycine molecules are chosen as
prototypical species because of the relative ease with
which they are computed. The accuracy of B3LYP/
DZVP calculations for Mg(NH3)n
1• and Ag(NH3)n
1 (n 5
1– 8) has recently been verified against a larger basis set
and also against experimental data [54]. Furthermore,
silver ion affinities of a number of small ligands, includ-
ing, ammonia, water, methanol, ethanol, acetonitrile,
and acetone, as determined using B3LYP/DZVP have
been found to be in good agreement with those mea-
sured via the threshold method [55].
The structures shown in Figure 5 fall into three major
categories. They are (a) five-membered ring structures
in which the silver ion is dicoordinated by the amino
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Figure 1. Product ion spectra of (a) the [b2 1 OH 1
107Ag]1 ion of AA and (b) the [M 1 107Ag]1 ion
of AA (the fragment ion at m/z 5 214, nominally [M 2 C3H3N]
1, is an unconventional ion formed
most likely from hydration of the [b1 1 OH 1 Ag]
1/[y1 2 H 1 Ag]
1 ion with residual water in the
nitrogen collision gas); (c) the [b3 1 OH 1
107Ag]1 ion of AAAAA and (d) the [M 1 107Ag]1 ion of
AAA (unconventional ions and their nominal assignments: m/z 5 285, [M 2 C3H3N]
1; m/z 5 214,
[m/z 5 267 2 C3H3N]
1; m/z 5 239, [m/z 5 285 2 CH2O2]
1; and m/z 5 224, [m/z 5 285 2
CH3NO2]
1). All Ecm 5 1.5 eV.
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nitrogen and the carbonyl oxygen atom of the first
residue, structures 1, 3, and 8; (b) multiple ring struc-
tures in which the silver ion is chelated by three or four
atoms, structures 4 and 7; and (c) silver salts in which
the silver ion is bound to the carboxylate anion of the
zwitterionic amino acid or peptide, structures 2, 5, 6,
and 10. It is evident that the silver salt structures in (c)
have higher energies than their corresponding silver
Figure 2. Product ion spectra of the [M 1 107Ag]1 ions of (a) leucine enkephalin and (b) leucine
enkephamide. Both Ecm 5 2.2 eV.
Figure 3. Product ion spectra of (a) the [y2 2 H 1
109Ag]1 ion of ALG and (b) the [M 1 109Ag]1 ion
of LG (m/z 5 212 is likely [m/z 5 240 2 CO]1). Both Ecm 5 2.2 eV.
167J Am Soc Mass Spectrom 2001, 12, 163–175 PRODUCT IONS FROM ARGENTINATED PEPTIDES
Figure 4. Product ion spectra of (a) the [b2 1 OH 1
107Ag]1 ion of GLA and (b) the [y2 2 H 1
107Ag]1 ion of GGL at Ecm 5 2.1 eV, and (c) the [b2 1 OH 1
107Ag]1 ion of GFA and (d) the [y2 2
H 1 107Ag]1 ion of GGF at Ecm 5 2.0 eV.
Table 1. Energies of structures calculated at the B3LYP/DZVP level of theory
Structure
Electronic energy
(Hartrees)
Zero-point energy
(kcal/mol)
Relative enthalpy at 298 K
(kcal/mol)
Relative free energy at 298 K
(kcal/mol)
Argentinated glycine
1 25483.75922 51.8 0.0 0.0
2 25483.75150 51.8 4.8 5.3
Argentinated glycylglycine
3 25691.81403 86.9 0.0 0.0
4 25691.81173 86.7 1.4 1.2
5 25691.80124 85.4 8.0 8.5
6 25691.79527 87.6 11.8 11.3
Argentinated glycylglycylglycine
7 25899.87332 122.1 0.0 0.0
8 25899.86170 121.8 7.2 9.2
9 25899.85506 122.3 11.7 13.4
10 25899.83823 121.7 21.8 24.0
[b2 2 H 1 Ag]
1
13 25615.32789 69.6 0.0 0.0
14 25615.31295 69.4 9.4 9.0
15 25615.29696 68.4 19.4 20.2
[a2 2 H 1 Ag]
1
16 25501.95559 61.8 0.0 0.0
17 25501.95048 62.0 3.2 2.8
18 25501.93194 60.8 14.8 15.4
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Figure 5. Optimized key argentinated (A) glycine, (B) glycylglycine, and (C) glycylglycylglycine
structures using B3LYP/DZVP: grey circles are carbon atoms and small circles are hydrogen atoms;
bond distances are in Ångstroms.
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complex structures in (a) and (b). For glycine, 2 is 5.3
kcal/mol higher in free energy than 1. For glycylgly-
cine, 5 and 6 are considerably higher in free energy than
the lowest energy five-membered ring structure, 3; the
lowest energy multiple ring structure, 4, is only 1.2
kcal/mol higher in energy than 3. This last trend is
reversed for the tripeptide, glycylglycylglycine; the
entropy loss in binding of the fourth ligand is more than
offset by the lowering of the enthalpy and the tetraco-
ordinated multiple ring structure, 7, is lower in free
energy than the five-membered ring structure, 8. The
Ag1 ion has a d10 electronic configuration. For coordi-
nation with small identical ligands, such as ammonia,
Ag1 binding enthalpies are characterized by two rela-
tively strong bonds with the first two ligands (bond
enthalpies 5 40.1 and 36.1 kcal/mol for the first and
second ammonia molecules) and relatively weak bonds
for the third and the fourth ligands (bond enthalpies 5
15.1 and 11.0 for the third and fourth ammonia mole-
cules) [54]. For ammonia, the free energy changes for
binding with the fifth ligand and beyond are positive
[54]. These observations are consistent with the findings
in this study in that tri- and even tetracoordination of
Ag1 occur in the gas phase when the ligation sites of a
complex ligand, e.g., an oligopeptide, are strategically
positioned around the ion.
Zwitterionic structures play a crucial role in the
structure, function and activity of proteins and peptides
in solution; however, their importance in the gas-phase
chemistry of these biomolecules is much less well
established. Although there is strong evidence suggest-
ing that zwitterionic conformers of glycine and oli-
gopeptides comprising glycine and alanine residues are
noncompetitive in the gas phase [56–64], recent exper-
imental and DFT results indicate that K1-, Rb1-, and
Cs1-containing arginine has this highly basic residue
present as a zwitterion, whereas Li1- and Na1-contain-
ing arginine has arginine present in a neutral conformer
[65]. Furthermore, there is also evidence that salt-bridge
interactions occur in the gas phase [21, 58, 66–68], e.g.,
the most stable structure of protonated bradykinin is
believed to be one in which both terminal arginine
residues are protonated and they interact via the dep-
rotonated carboxylate of the C-terminus [66]. Thus,
evidence strongly suggests that zwitterionic structures
are favored in the presence of highly basic residues and
large cations. Although the residues in the oligopep-
tides examined in this present study are low in basicity,
the silver ion is relatively large and polarizable; further-
more, the free energies of the most stable salt structures
in Figure 5 are only larger than their corresponding
(nonzwitterionic) silver complex structures by 5–8
kcal/mol. As a result, the existence of zwitterionic
argentinated peptide structures, especially as collision-
ally activated precursor structures that ultimately frag-
ment to form the experimentally observed product ions,
cannot be ruled out without a proper investigation. This
is particularly relevant for the [bn 1 OH 1 Ag]
1 ions,
whose alkali-metal-adducted equivalent, the [bn 1
OH 1 Li]1 and [bn 1 OH 1 Na]
1 ions, have been pro-
posed to form via metal salt structures in which the
Figure 6. Product ion spectra of (a) the [M 1 109Ag]1 ion and (b) the [M 1 107Ag]1 ion of
betaine-AG at Ecm 5 2.0 eV, and (c) the [M 1
109Ag]1 ion and (d) the [M 1 107Ag]1 ion of
betaine-AGA at Ecm 5 1.5 eV.
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metal ion is bound to the carboxylate anion of the
zwitterionic peptide [68–71].
To investigate the possible role of zwitterionic pep-
tide structures in the formation of argentinated product
ions, we have examined the collision-induced dissocia-
tion of two silver-containing, naturally zwitterionic tri-
and tetrapeptide, betaine-AG and betaine-AGA, respec-
tively. Betaine, (carboxymethyl)trimethylammonium, is
a widely occurring albeit “nonessential” amino acid. It
is, by virtue of this quaternary ammonium functional-
ity, a natural zwitterion, and its incorporation into a
peptide chain produces zwitterionic peptides. Figure 6
shows the product ion spectra of (a) the [M 1 109Ag]1
and (b) the [M 1 107Ag]1 ions of betaine-AG, and (c)
the [M 1 109Ag]1 and (d) the [M 1 107Ag]1 ions of
betaine-AGA. A comparison of the product ion spectra
of the [M 1 109Ag]1 and the [M 1 107Ag]1 ions reveals
quickly that most of the fragment ions in these two
betaine-containing peptides are nonsilver containing.
Furthermore, conventional silver-containing product
ions, i.e., the [bn 2 H 1 Ag]
1, [an 2 H 1 Ag]
1, [yn 2
H 1 Ag]1, and [bn 1 OH 1 Ag]
1 ions, are virtually
absent in the fragmentation of argentinated betaine-AG
and only the [b3 2 H 1 Ag]
1 and [b3 1 OH 1 Ag]
1
ions are present in significant abundance in that of
argentinated betaine-AGA. The best metal ion binding
site of a zwitterionic peptide is the C-terminal carbox-
ylate anion; thus the [M 1 Ag]1 ions of betaine-AG and
betaine-AGA are permanent silver salt structures. The
sparsity of conventional argentinated product ions pro-
vides strong experimental evidence that salt structures
are not precursors to fragmentation.
A second piece of supporting experimental evidence
comes from the fragmentation of the [M 2 H 1 2Ag]1
ions of oligopeptides. For these ions, coulombic repul-
sion dictates that the silver ions be spaced as widely
apart as possible; this coupled with the higher acidity of
the C-terminal carboxylic acid versus the amide hydro-
gen (DH°acid (CH3COO
2) 5 348.6 versus DH°acid (N-
methylacetamide anion) 5 361.9 kcal/mol [72]), means
Scheme 1
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that the most stable structure is likely one in which one
of the silver ions is attached to the carboxylate anion (to
form a silver salt) and the other is ligated at the
N-terminal end of the peptide (probably to the N-
terminal nitrogen and carbonyl oxygens). Again, if the
salt structure were a crucial precursor to fragmentation,
then one would expect to find abundant fragment ions
with the salt feature preserved, i.e., abundant [bn 2
2H 1 2Ag]1, [an 2 2H 1 2Ag]
1, and [bn 1 O 1
2Ag]1 ions; these, however, are not observed.
Schemes 1 and 2 show proposed mechanisms of the
formation of the [b2 1 OH 1 Ag]
1 and the [y2 2 H 1
Ag]1 ions, respectively, from argentinated GGG. In
both schemes, the starting structure is the most stable,
tetracoordinated, conformation, 7. Collisional activation
results in cleavage of some of the bonds and adoption of
a different conformation, which subsequently leads to
fragmentation. In Scheme 1, 9 is a conformer in which
the Ag1 is dicoordinated by the N-terminal nitrogen
and the carbonyl oxygen of the second residue; this
conformer is 13.4 kcal/mol higher in free energy than 7,
a difference in energy easily accessible via collisional
activation. Attack of the second carbonyl carbon by the
lone pair of electrons on the carbonyl oxygen of the
C-terminus results in the classical “tetrahedral interme-
diate” of amide hydrolysis, 11 [73–76]. The carbonyl
oxygen is the more basic site and a better nucleophile
than the hydroxyl oxygen [77–84]; the latter, however,
was employed in earlier proposed mechanisms [85, 86].
The proton transfer from the C-terminal hydroxyl to the
N-terminal amino group and the fragmentation of the
five-membered ring of the tetrahedral intermediate are
shown as a concerted process for simplicity. The proton
transfer and fragmentation may be a two-step process
Scheme 2
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and proton transfer may precede fragmentation or vice
versa. The products are CO and NH¢CH2 and 6, a
silver-salt structure of argentinated GG, which subse-
quently isomerizes to 3, the lowest energy structure at
11.3 kcal/mol lower in free energy than 6. The proposed
mechanism requires the transfer of the carboxylic pro-
ton to the N-terminal nitrogen. The equivalent transfer
of a C-terminal amide proton to the N-terminal nitro-
gen, as would be the case for a tripeptide having a
C-terminal amide functional group, is comparatively
more difficult as the amide is considerably less acidic
{DH°acid (CH3COO
2) 5 348.6 versus DH°acid (N-methyla-
cetamide anion) 5 361.9 kcal/mol [72]} and is postu-
lated to be noncompetitive with other fragmentation
pathways (such as the formation of the [b2 2 H 1 Ag]
1
and [a2 2 H 1 Ag]
1 ions). Similarly, the transfer of a
methyl or ethyl group or a C–H proton from a C-
terminal ester group to the N-terminal nitrogen is also
energetically unfavorable and hence these transfers are
not observed. As a consequence, only oligopeptides that
have C-terminal carboxylic groups are capable of pro-
ducing the [bn 1 OH 1 Ag]
1 ions; furthermore, forma-
tion of [bn 1 NH2 1 Ag]
1, [bn 1 OCH3 1 Ag]
1 and
[bn 1 OC2H5 1 Ag]
1 ions is also noncompetitive.
These conclusions are consistent with experimental
observations detailed earlier.
In Scheme 2, 12 is a tricoordinate silver complex
formed from 7, the lowest energy conformer of argen-
tinated GGG. Attack on the first carbonyl carbon by the
lone pair of electrons on the N-terminal nitrogen atom,
proton transfer from the amino nitrogen to the amide
nitrogen of the first residue, and elimination of the
aziridinone produce the [y2 2 H 1 Ag]
1 ion, 4, which
then isomerizes to 3 (3 is lower in free energy than 4 by
1.4 kcal/mol). In contrast to Scheme 1, the reactions are
shown in discrete steps for clarity; they may in reality
be concerted. The transfer of an amino proton to the
amide nitrogen is consistent with the experimental
results obtained with D2O/CH3OD, which shows that
the ionic fragment receives a N–H or O–H proton from
the neutral fragment. N-acetyl and N-benzoyl tripep-
tides have one remaining hydrogen attached to the first
amide nitrogen atom; hence formation of the [y2 2 H 1
Ag]1 ions is unaffected. Several mechanistic details in
Scheme 2, e.g., elimination of an aziridinone and trans-
fer of an amino proton to the amide nitrogen adjacent to
the cleaved peptide bond, are shared with those pro-
Figure 7. Optimized structures for the (A) [b2 2 H 1 Ag]
1 and (B) [a2 2 H 1 Ag]
1 ions of
glycylglycine using B3LYP/DZVP. See Figure 5 for details.
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posed for the fragmentation of protonated tripeptides
to form the equivalent y2 ion [36, 53].
[b2 2 H 1 Ag]
1
As mentioned earlier, based on the product ions they
observed, Lee et al. [46] proposed that the [b2 2 H 1
Ag]1 ion has an oxazolone structure in which the silver
ion is chelated by the amino as well as by the ring
nitrogen atoms. The three possible oxazolone structures
in which the silver(I) ion is s bonded are listed in Table
1 and shown in Figure 7. Harmonic frequency calcula-
tions showed that all three structures are at minima.
Structure 13, in which the silver ion is chelated by both
nitrogen atoms, has the lowest energy. Structure 14,
where the silver ion is chelated by both the amino
nitrogen and ring oxygen atoms, is less favored by 9.0
kcal/mol. It is noteworthy that in both 13 and 14 the
silver ion is almost equidistant from its two chelating
atoms. Structure 15 is the only isomer in which the
silver ion coordinates in a monodentate fashion to the
carbonyl oxygen. Not too surprisingly, it is the least
energetically favored structure of these ions.
[a2 2 H 1 Ag]
1
Table 1 and Figure 7 also give the energies and ion
structures of the [a2 2 H 1 Ag]
1 ions. Structures 16, in
which the silver ion is chelated to the amino nitrogen
and the carbonyl oxygen atoms, and 17, where it is
chelated to the amino and imino nitrogen atoms, are
separated by only 2.8 kcal/mol, and are expected to be
the predominant [a2 2 H 1 Ag]
1 ion structures.
Again, the silver ion is almost equidistant from its two
ligands in both structures. A comparison of the relative
free energies of 16 and 17, where the silver interaction
with the amino nitrogen has been replaced by one with
the carbonyl oxygen, shows that the silver interaction
with the amino nitrogen is stronger than that with the
carbonyl oxygen by 12.6 kcal/mol. This is probably due
partly to the higher silver(I) ion affinity of nitrogen
relative to that of oxygen [39, 43, 87] and partly to
increased ring strain in the four-membered ring present
in 18 as opposed to the five-membered ring structures
in 16 and 17.
Conclusion
Combined mass spectrometric and DFT results reveal
that the [bn 1 OH 1 Ag]
1 ions and the [yn 2 H 1
Ag]1 ions formed from the fragmentation of oligopep-
tides are argentinated truncated peptides. For argenti-
nated glycylglycylglycine, the most stable conformer
contains a tetracoordinate silver ion chelated by the
amino nitrogen and the three carbonyl oxygen atoms. It
is proposed that this conformer isomerizers to different
higher-energy conformers that fragment to yield even-
tually the [bn 1 OH 1 Ag]
1 and the [yn 2 H 1 Ag]
1
ions. DFT results confirm that the [b2 2 H 1 Ag]
1 ion
and the [a2 2 H 1 Ag]
1 ions, formed from the dissoci-
ation of argentinated glycylglycylglycine, are an argen-
tinated oxazolone and an argentinated immonium ion,
respectively.
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